| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
| Exhibit No. | |||||
| 99.1 | |||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL) | ||||
| Blend Labs, Inc. | ||||||||
Date: | ||||||||
| By: | /s/ Jason Ream | |||||||
| Name: | Jason Ream | |||||||
| Title: | Head of Finance and Administration (Principal Financial Officer) | |||||||
| $ in millions | |||||
| Q3 2026 Guidance | |||||
| Total Revenue | $31.5M - $33.5M | ||||
| Non-GAAP Operating Income | $3.5M - $4.5M | ||||
| June 30, 2026 | December 31, 2025 | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 23,311 | $ | 45,061 | |||||||
| Marketable securities and other investments | 21,556 | 24,739 | |||||||||
| Trade and other receivables, net of allowance for credit losses of $135 and $112, respectively | 14,425 | 8,786 | |||||||||
| Prepaid expenses and other current assets | 16,594 | 17,257 | |||||||||
| Current assets held for sale from discontinued operations | — | 3,958 | |||||||||
| Total current assets | 75,886 | 99,801 | |||||||||
| Property and equipment, net | 21,936 | 22,997 | |||||||||
| Operating lease right-of-use assets | 1,953 | 1,394 | |||||||||
| Deferred contract costs | 3,213 | 3,425 | |||||||||
| Other non-current assets | 40,578 | 41,425 | |||||||||
| Non-current assets held for sale from discontinued operations | — | 1,003 | |||||||||
| Total assets | $ | 143,566 | $ | 170,045 | |||||||
| Liabilities, redeemable equity and stockholders’ equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 418 | $ | 1,858 | |||||||
| Deferred revenue | 31,483 | 19,385 | |||||||||
| Accrued compensation | 3,541 | 4,560 | |||||||||
| Other current liabilities | 11,262 | 11,523 | |||||||||
| Current liabilities held for sale from discontinued operations | — | 2,128 | |||||||||
| Total current liabilities | 46,704 | 39,454 | |||||||||
| Other non-current liabilities | 2,083 | 1,569 | |||||||||
| Total liabilities | 48,787 | 41,023 | |||||||||
| Commitments and contingencies | |||||||||||
Series A redeemable convertible preferred stock, par value $0.00001 per share: 200,000 shares authorized as of June 30, 2026 and December 31, 2025, 150 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 169,153 | 159,495 | |||||||||
| Stockholders’ equity: | |||||||||||
Class A, Class B and Class C Common Stock, par value $0.00001 per share: 3,000,000 (Class A 1,800,000, Class B 600,000, Class C 600,000) shares authorized as of June 30, 2026 and December 31, 2025; 236,513 (Class A 233,257, Class B 3,256, Class C 0) and 256,043 (Class A 252,787, Class B 3,256, Class C 0) shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 2 | 2 | |||||||||
| Additional paid-in capital | 1,326,309 | 1,360,704 | |||||||||
| Accumulated other comprehensive income | 623 | 597 | |||||||||
| Accumulated deficit | (1,401,308) | (1,391,776) | |||||||||
| Total stockholders’ equity | (74,374) | (30,473) | |||||||||
| Total liabilities, redeemable equity and stockholders’ equity | $ | 143,566 | $ | 170,045 | |||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Revenue | |||||||||||||||||||||||
| Software platform | $ | 31,404 | $ | 29,465 | $ | 59,397 | $ | 53,767 | |||||||||||||||
| Professional services | 2,433 | 2,164 | 5,283 | 4,707 | |||||||||||||||||||
| Total revenue | 33,837 | 31,629 | 64,680 | 58,474 | |||||||||||||||||||
| Cost of revenue | |||||||||||||||||||||||
| Software platform | 7,152 | 6,560 | 12,920 | 12,457 | |||||||||||||||||||
| Professional services | 1,800 | 1,713 | 3,510 | 3,660 | |||||||||||||||||||
| Total cost of revenue | 8,952 | 8,273 | 16,430 | 16,117 | |||||||||||||||||||
| Gross profit | 24,885 | 23,356 | 48,250 | 42,357 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Research and development | 8,683 | 7,486 | 18,096 | 15,329 | |||||||||||||||||||
| Sales and marketing | 6,740 | 6,950 | 12,938 | 14,137 | |||||||||||||||||||
| General and administrative | 11,034 | 13,718 | 23,187 | 24,950 | |||||||||||||||||||
| Restructuring | 4 | 28 | 666 | 747 | |||||||||||||||||||
| Total operating expenses | 26,461 | 28,182 | 54,887 | 55,163 | |||||||||||||||||||
| Loss from operations | (1,576) | (4,826) | (6,637) | (12,806) | |||||||||||||||||||
| Other income (expense), net | 221 | 1,018 | 261 | 2,132 | |||||||||||||||||||
| Loss before income taxes | (1,355) | (3,808) | (6,376) | (10,674) | |||||||||||||||||||
| Income tax expense | (119) | (41) | (182) | (71) | |||||||||||||||||||
| Loss before equity in losses of equity method investees | (1,474) | (3,849) | (6,558) | (10,745) | |||||||||||||||||||
| Equity in losses of equity method investees, net of tax | (338) | — | (719) | — | |||||||||||||||||||
| Loss from continuing operations | (1,812) | (3,849) | (7,277) | (10,745) | |||||||||||||||||||
| Income (loss) from discontinued operations | 329 | (2,998) | (2,255) | (5,801) | |||||||||||||||||||
| Net loss | (1,483) | (6,847) | (9,532) | (16,546) | |||||||||||||||||||
| Less: Net loss attributable to noncontrolling interest included in discontinued operations | — | — | — | 182 | |||||||||||||||||||
| Net loss attributable to Blend Labs, Inc. | (1,483) | (6,847) | (9,532) | (16,364) | |||||||||||||||||||
| Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations | — | — | — | (1,254) | |||||||||||||||||||
| Less: Accretion of Series A redeemable convertible preferred stock to redemption value | (4,927) | (4,376) | (9,658) | (8,578) | |||||||||||||||||||
| Net loss attributable to Blend Labs, Inc. common stockholders | $ | (6,410) | $ | (11,223) | $ | (19,190) | $ | (26,196) | |||||||||||||||
| Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted: | |||||||||||||||||||||||
| Continuing operations | $ | (0.03) | $ | (0.03) | $ | (0.07) | $ | (0.07) | |||||||||||||||
| Discontinued operations | $ | 0.00 | $ | (0.01) | $ | (0.01) | $ | (0.03) | |||||||||||||||
| Net loss per share attributable to Blend Labs, Inc. common stockholders | $ | (0.03) | $ | (0.04) | $ | (0.08) | $ | (0.10) | |||||||||||||||
| Weighted average shares used in calculating net loss per share: | |||||||||||||||||||||||
| Basic and diluted | 239,909 | 259,211 | 247,726 | 259,004 | |||||||||||||||||||
| Comprehensive loss: | |||||||||||||||||||||||
| Net loss | $ | (1,483) | $ | (6,847) | $ | (9,532) | $ | (16,546) | |||||||||||||||
| Unrealized loss on marketable securities | (58) | (44) | (164) | (38) | |||||||||||||||||||
| Foreign currency translation gain (loss) | 18 | (7) | 190 | (50) | |||||||||||||||||||
| Comprehensive loss | (1,523) | (6,898) | (9,506) | (16,634) | |||||||||||||||||||
| Less: Comprehensive loss attributable to noncontrolling interest included in discontinued operations | — | — | — | 182 | |||||||||||||||||||
| Comprehensive loss attributable to Blend Labs, Inc. | $ | (1,523) | $ | (6,898) | $ | (9,506) | $ | (16,452) | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Operating activities | |||||||||||||||||||||||
| Net loss | $ | (1,483) | $ | (6,847) | $ | (9,532) | $ | (16,546) | |||||||||||||||
| Less: Net income (loss) from discontinued operations | 329 | (2,998) | (2,255) | (5,801) | |||||||||||||||||||
| Net loss from continuing operations | (1,812) | (3,849) | (7,277) | (10,745) | |||||||||||||||||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||||||||||||||||||
| Stock-based compensation | 6,978 | 7,582 | 13,758 | 13,678 | |||||||||||||||||||
| Depreciation and amortization | 1,514 | 640 | 2,851 | 1,047 | |||||||||||||||||||
| Amortization of deferred contract costs | 317 | 431 | 792 | 746 | |||||||||||||||||||
| Amortization of operating lease right-of-use assets | 87 | 122 | 210 | 199 | |||||||||||||||||||
Equity in losses of equity method investees, net of tax | 338 | — | 719 | — | |||||||||||||||||||
| Other | 210 | (178) | 622 | (316) | |||||||||||||||||||
| Changes in operating assets and liabilities: | |||||||||||||||||||||||
| Trade and other receivables | 3,398 | (4,408) | (5,663) | (506) | |||||||||||||||||||
| Prepaid expenses and other assets, current and non-current | (765) | (1,583) | 379 | (719) | |||||||||||||||||||
| Deferred contract costs, non-current | 169 | (178) | 212 | (531) | |||||||||||||||||||
| Accounts payable | 159 | (1,465) | (1,440) | (419) | |||||||||||||||||||
| Deferred revenue | (2,539) | (556) | 12,098 | 12,352 | |||||||||||||||||||
| Accrued compensation | (444) | (1,195) | (987) | (684) | |||||||||||||||||||
| Operating lease liabilities | (86) | (974) | (206) | (1,921) | |||||||||||||||||||
| Other liabilities, current and non-current | 214 | 185 | 132 | 2,204 | |||||||||||||||||||
| Net cash provided by (used in) operating activities - continuing operations | 7,738 | (5,426) | 16,200 | 14,385 | |||||||||||||||||||
| Net cash provided by (used in) operating activities - discontinued operations | 189 | (1,076) | (921) | (771) | |||||||||||||||||||
| Net cash provided by (used in) operating activities | 7,927 | (6,502) | 15,279 | 13,614 | |||||||||||||||||||
| Investing activities | |||||||||||||||||||||||
| Purchases of marketable securities | — | (11,873) | (4,966) | (23,749) | |||||||||||||||||||
| Sale of available-for-sale securities | — | 11 | — | 859 | |||||||||||||||||||
| Maturities of marketable securities | — | 8,800 | 8,000 | 27,727 | |||||||||||||||||||
| Additions to property, equipment and internal-use software development costs | (825) | (3,599) | (1,942) | (7,912) | |||||||||||||||||||
| Investment in non-marketable equity securities | — | (4,000) | — | (4,000) | |||||||||||||||||||
| Net cash (used in) provided by investing activities - continuing operations | (825) | (10,661) | 1,092 | (7,075) | |||||||||||||||||||
| Net cash provided by (used in) investing activities - discontinued operations | 140 | (36) | 1,110 | (120) | |||||||||||||||||||
| Net cash (used in) provided by investing activities | (685) | (10,697) | 2,202 | (7,195) | |||||||||||||||||||
| Financing activities | |||||||||||||||||||||||
| Proceeds from exercises of stock options, including early exercises, net of repurchases | — | 430 | 96 | 793 | |||||||||||||||||||
| Taxes paid related to net share settlement of equity awards | (937) | (2,531) | (2,064) | (5,502) | |||||||||||||||||||
| Share repurchases | (20,405) | (1,550) | (37,241) | (4,118) | |||||||||||||||||||
| Net cash used in financing activities - continuing operations | (21,342) | (3,651) | (39,209) | (8,827) | |||||||||||||||||||
| Effect of exchange rates on cash, cash equivalents, and restricted cash | (19) | — | (24) | — | |||||||||||||||||||
| Net decrease in cash, cash equivalents, and restricted cash | (14,119) | (20,850) | (21,752) | (2,408) | |||||||||||||||||||
| Cash, cash equivalents, and restricted cash at beginning of period | 39,365 | 67,979 | 46,998 | 49,537 | |||||||||||||||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 25,246 | $ | 47,129 | $ | 25,246 | $ | 47,129 | |||||||||||||||
| Less: Cash, cash equivalents and restricted cash included in current assets held for sale from discontinued operations | — | 5,607 | — | 5,607 | |||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Cash, cash equivalents and restricted cash, end of period, excluding current assets held for sale from discontinued operations | $ | 25,246 | $ | 41,522 | $ | 25,246 | $ | 41,522 | |||||||||||||||
Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets: | |||||||||||||||||||||||
| Cash and cash equivalents | $ | 23,311 | $ | 36,499 | $ | 23,311 | $ | 36,499 | |||||||||||||||
| Restricted cash | 1,935 | 5,023 | 1,935 | 5,023 | |||||||||||||||||||
| Total cash, cash equivalents, and restricted cash | $ | 25,246 | $ | 41,522 | $ | 25,246 | $ | 41,522 | |||||||||||||||
| Supplemental disclosure of cash flow information: | |||||||||||||||||||||||
| Cash paid for income taxes | |||||||||||||||||||||||
| State and local | |||||||||||||||||||||||
| Texas | $ | 80 | $ | 64 | $ | 80 | $ | 64 | |||||||||||||||
| Foreign | |||||||||||||||||||||||
| India | $ | 57 | $ | 135 | $ | 111 | $ | 268 | |||||||||||||||
| Total income taxes paid, net | $ | 137 | $ | 199 | $ | 191 | $ | 332 | |||||||||||||||
| Cash paid for interest | $ | — | $ | — | $ | — | $ | — | |||||||||||||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||||||||||||||||||||
| Reclassification of redeemable noncontrolling interest related to discontinued operations to equity | $ | — | $ | — | $ | — | $ | 52,675 | |||||||||||||||
| Operating lease liabilities arising from obtaining new or modified right-of-use assets | $ | 760 | $ | 1,640 | $ | 760 | $ | 1,640 | |||||||||||||||
| Stock-based compensation included in capitalized internal-use software development costs | $ | 119 | $ | 1,175 | $ | 238 | $ | 2,345 | |||||||||||||||
| Accretion of redeemable noncontrolling interest related to discontinued operations to redemption value | $ | — | $ | — | $ | — | $ | 1,254 | |||||||||||||||
| Accretion of Series A redeemable convertible preferred stock to redemption value | $ | 4,927 | $ | 4,376 | $ | 9,658 | $ | 8,578 | |||||||||||||||
| Consideration receivable in connection with the sale of title assets | $ | — | $ | — | $ | 389 | $ | — | |||||||||||||||
| Capitalized internal-use software development costs included in accrued compensation | $ | 58 | $ | 201 | $ | 58 | $ | 201 | |||||||||||||||
| Three Months Ended June 30, | |||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| YoY change | |||||||||||||||||||||||
| Mortgage Suite | $ | 19,240 | 57 | % | $ | 17,987 | 57 | % | 7 | % | |||||||||||||
| Consumer Banking Suite | 12,164 | 36 | % | 11,478 | 36 | % | 6 | % | |||||||||||||||
| Total software platform | 31,404 | 93 | % | 29,465 | 93 | % | 7 | % | |||||||||||||||
| Professional services | 2,433 | 7 | % | 2,164 | 7 | % | 12 | % | |||||||||||||||
| Total revenue | $ | 33,837 | 100 | % | $ | 31,629 | 100 | % | 7 | % | |||||||||||||
| Six Months Ended June 30, | |||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| YoY change | |||||||||||||||||||||||
| Mortgage Suite | $ | 36,472 | 56 | % | $ | 32,645 | 56 | % | 12 | % | |||||||||||||
| Consumer Banking Suite | 22,925 | 35 | % | 21,122 | 36 | % | 9 | % | |||||||||||||||
| Total software platform | 59,397 | 92 | % | 53,767 | 92 | % | 10 | % | |||||||||||||||
| Professional services | 5,283 | 8 | % | 4,707 | 8 | % | 12 | % | |||||||||||||||
| Total revenue | $ | 64,680 | 100 | % | $ | 58,474 | 100 | % | 11 | % | |||||||||||||
| Three Months Ended June 30, | ||||||||||||||
| 2026 | 2025 | |||||||||||||
| Gross Profit Reconciliation | Gross Profit | Gross Margin | Gross Profit | Gross Margin | ||||||||||
| Blend Platform | ||||||||||||||
| GAAP Software platform | $ | 24,252 | 77 | % | $ | 22,905 | 78 | % | ||||||
Stock-based compensation(1) | 7 | 1 | ||||||||||||
Amortization of capitalized internal-use software(7) | 1,449 | 601 | ||||||||||||
| Non-GAAP Software platform | 25,708 | 82 | % | 23,507 | 80 | % | ||||||||
| GAAP Professional services | 633 | 26 | % | 451 | 21 | % | ||||||||
Stock-based compensation(1) | 139 | 115 | ||||||||||||
Amortization of capitalized internal-use software(7) | — | — | ||||||||||||
| Non-GAAP Professional services | 772 | 32 | % | 566 | 26 | % | ||||||||
| GAAP Gross Profit | 24,885 | 74 | % | 23,356 | 74 | % | ||||||||
Stock-based compensation(1) | 146 | 116 | ||||||||||||
Amortization of capitalized internal-use software(7) | 1,449 | 601 | ||||||||||||
| Non-GAAP Gross Profit | $ | 26,480 | 78 | % | $ | 24,073 | 76 | % | ||||||
| Six Months Ended June 30, | ||||||||||||||
| 2026 | 2025 | |||||||||||||
| Gross Profit Reconciliation | Gross Profit | Gross Margin | Gross Profit | Gross Margin | ||||||||||
| Blend Platform | ||||||||||||||
| GAAP Software platform | $ | 46,477 | 78 | % | $ | 41,310 | 77 | % | ||||||
Stock-based compensation(1) | 10 | 2 | ||||||||||||
Amortization of capitalized internal-use software(7) | 2,722 | 989 | ||||||||||||
| Non-GAAP Software platform | 49,209 | 83 | % | 42,301 | 79 | % | ||||||||
| GAAP Professional services | 1,773 | 34 | % | 1,047 | 22 | % | ||||||||
Stock-based compensation(1) | 258 | 284 | ||||||||||||
Amortization of capitalized internal-use software(7) | — | — | ||||||||||||
| Non-GAAP Professional services | 2,031 | 38 | % | 1,331 | 28 | % | ||||||||
| GAAP Gross Profit | 48,250 | 75 | % | 42,357 | 72 | % | ||||||||
Stock-based compensation(1) | 268 | 286 | ||||||||||||
Amortization of capitalized internal-use software(7) | 2,722 | 989 | ||||||||||||
| Non-GAAP Gross Profit | $ | 51,240 | 79 | % | $ | 43,632 | 75 | % | ||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| GAAP operating expenses | $ | 26,461 | $ | 28,182 | $ | 54,887 | $ | 55,163 | |||||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||
Stock-based compensation(1) | 6,832 | 7,466 | 13,490 | 13,392 | |||||||||||||||||||
Workforce reduction costs(2) | 4 | 28 | 666 | 747 | |||||||||||||||||||
Abandoned and terminated facilities costs(3) | — | 892 | — | 1,399 | |||||||||||||||||||
Litigation contingencies and related professional services costs(4) | — | 71 | — | 859 | |||||||||||||||||||
Transaction-related costs(5) | 4 | 248 | 178 | 394 | |||||||||||||||||||
Impairment of capitalized internal-use software(6) | 118 | 31 | 378 | 112 | |||||||||||||||||||
| Non-GAAP operating expenses | $ | 19,503 | $ | 19,446 | $ | 40,175 | $ | 38,260 | |||||||||||||||
| GAAP loss from operations | $ | (1,576) | $ | (4,826) | $ | (6,637) | $ | (12,806) | |||||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||
Stock-based compensation(1) | 6,978 | 7,582 | 13,758 | 13,678 | |||||||||||||||||||
Workforce reduction costs(2) | 4 | 28 | 666 | 747 | |||||||||||||||||||
Abandoned and terminated facilities costs(3) | — | 892 | — | 1,399 | |||||||||||||||||||
Litigation contingencies and related professional services costs(4) | — | 71 | — | 859 | |||||||||||||||||||
Transaction-related costs(5) | 4 | 248 | 178 | 394 | |||||||||||||||||||
Impairment of capitalized internal-use software(6) | 118 | 31 | 378 | 112 | |||||||||||||||||||
Amortization of capitalized internal-use software(7) | 1,449 | 601 | 2,722 | 989 | |||||||||||||||||||
| Non-GAAP income from operations | $ | 6,977 | $ | 4,627 | $ | 11,065 | $ | 5,372 | |||||||||||||||
GAAP operating margin | (5) | % | (15) | % | (10) | % | (22) | % | |||||||||||||||
Non-GAAP operating margin | 21 | % | 15 | % | 17 | % | 9 | % | |||||||||||||||
| GAAP net loss from continuing operations | $ | (1,812) | $ | (3,849) | $ | (7,277) | $ | (10,745) | |||||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||
Stock-based compensation(1) | 6,978 | 7,582 | 13,758 | 13,678 | |||||||||||||||||||
Workforce reduction costs(2) | 4 | 28 | 666 | 747 | |||||||||||||||||||
Abandoned and terminated facilities costs(3) | — | 892 | — | 1,399 | |||||||||||||||||||
Litigation contingencies and related professional services costs(4) | — | 71 | — | 859 | |||||||||||||||||||
Transaction-related costs(5) | 4 | 248 | 178 | 394 | |||||||||||||||||||
Impairment of capitalized internal-use software(6) | 118 | 31 | 378 | 112 | |||||||||||||||||||
Amortization of capitalized internal-use software(7) | 1,449 | 601 | 2,722 | 989 | |||||||||||||||||||
Foreign currency gains and losses(8) | 51 | 17 | 337 | (3) | |||||||||||||||||||
Equity in losses of equity method investees(9) | 338 | — | 719 | — | |||||||||||||||||||
| Non-GAAP net income from continuing operations | $ | 7,130 | $ | 5,621 | $ | 11,481 | $ | 7,430 | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| GAAP diluted net loss per share from continuing operations attributable to common stockholders | $ | (0.03) | $ | (0.03) | $ | (0.07) | $ | (0.07) | |||||||||||||||
Per share impact of non-GAAP expenses(10) | 0.03 | 0.03 | 0.07 | 0.07 | |||||||||||||||||||
Non-GAAP diluted income (loss) per share from continuing operations attributable to common stockholders | $ | 0.00 | $ | 0.00 | $ | 0.00 | $ | 0.00 | |||||||||||||||
GAAP diluted weighted average shares used in calculating net loss per share | 239,909 | 259,211 | 247,726 | 259,004 | |||||||||||||||||||
Non-GAAP diluted weighted average shares used in calculating net income (loss) per share | 242,288 | 268,778 | 250,739 | 259,004 | |||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Net cash provided by (used in) operating activities - continuing operations | $ | 7,738 | $ | (5,426) | $ | 16,200 | $ | 14,385 | |||||||||||||||
| Additions to property, equipment and internal-use software development costs | (825) | (3,599) | (1,942) | (7,912) | |||||||||||||||||||
| Free cash flow | 6,913 | (9,025) | 14,258 | 6,473 | |||||||||||||||||||
| Revenue | $ | 33,837 | $ | 31,629 | $ | 64,680 | $ | 58,474 | |||||||||||||||
| Free cash flow margin | 20 | % | (29) | % | 22 | % | 11 | % | |||||||||||||||
| Notes: | |||||||||||||||||||||||
(1) Stock-based compensation represents the non-cash grant date fair value of stock-based instruments utilized to incentivize our employees, for which the expense is recognized over the applicable vesting or performance period. | |||||||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| Stock-based compensation by function: | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Cost of revenue | $ | 146 | $ | 116 | $ | 268 | $ | 286 | |||||||||||||||
| Research and development * | 1,496 | 1,272 | 3,157 | 2,956 | |||||||||||||||||||
| Sales and marketing | 794 | 618 | 1,076 | 1,338 | |||||||||||||||||||
| General and administrative | 4,542 | 5,576 | 9,257 | 9,098 | |||||||||||||||||||
| Total | $ | 6,978 | $ | 7,582 | $ | 13,758 | $ | 13,678 | |||||||||||||||
* Net of $0.1 million and $0.2 million of additions to capitalized internal-use software for the three and six months ended June 30, 2026 and $1.1 million and $2.3 million for the three and six months ended June 30, 2025 | ||||||||||||||||||||||||||
(2) Workforce reduction costs represent expenses incurred in connection with the workforce restructuring actions executed as part of our broader efforts to improve cost efficiency. | ||||||||||||||||||||||||||
| (3) Abandoned and terminated facilities costs represent charges related to the early termination of a leased facility and abandonment of another leased facility as part of our broader efforts to better align our operating structure with our business activities. | ||||||||||||||||||||||||||
(4) Litigation contingencies and related professional services costs represent reserves for legal settlements and related professional service fees that are unusual or infrequent costs associated with our operating activities. | ||||||||||||||||||||||||||
(5) Transaction-related costs include non-recurring financial advisory, legal, and other transactional costs incurred in connection with investing or divesting activities recorded within general and administrative expense. | ||||||||||||||||||||||||||
| (6) Impairment of capitalized internal-use software represents the non-cash expense related to the write-off of certain internal-use software projects. | ||||||||||||||||||||||||||
| (7) Amortization of capitalized internal-use software represents the non-cash amortization expense related to our developed technology that is amortized over the estimated useful life. | ||||||||||||||||||||||||||
(8) Foreign currency gains and losses include remeasurement of assets and liabilities from foreign currency into the functional currency in connection with our operations in India. | ||||||||||||||||||||||||||
| (9) Equity in losses of equity method investees reflects our share of the investees’ net loss under the equity method of accounting. | ||||||||||||||||||||||||||
(10) Per share impact of non-GAAP expenses represents the per share impact of aggregated non-GAAP items included in (1) through (9). | ||||||||||||||||||||||||||